Stockscreener 앱 받기
9.06
0.00%
0.00
전일 마감가:
$9.06
열려 있는:
$9.4
하루 거래량:
5,405
Relative Volume:
0.09
시가총액:
$34.40M
수익:
-
순이익/손실:
$-11.62M
주가수익비율:
-1.6179
EPS:
-5.6
순현금흐름:
$-6.91M
1주 성능:
-11.78%
1개월 성능:
-8.67%
6개월 성능:
+126.50%
1년 성능:
+74.90%
1일 변동 폭
$9.32
$9.8522
1주일 범위
$8.95
$10.41
52주 변동 폭
$2.31
$13.70
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
명칭
Coeptis Therapeutics Holdings Inc
전화
724-934-6467
주소
105 BRADFORD ROAD, SUITE 420, WEXFORD
COEP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COEP
COEPTIS THERAPEUTICS INC
|
6.99 | 2.70M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.35 | 372.90M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
10.65 | 211.65M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.93 | 122.73M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.35 | 397.07M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.16 | 340.19M | 2.07B | -1.42B | -1.37B | -0.6765 |
Coeptis Therapeutics Holdings Inc 주식(COEP)의 최신 뉴스
SNAP Biosciences' Agreement Leverages Monarch's Technology for C - GuruFocus
Monarch Therapeutics and SNAP Biosciences Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology - marketscreener.com
Monarch Therapeutics, SNAP Biosciences enter licensing agreement - TipRanks
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology - The Manila Times
Game-Changing Cancer Therapy Partnership: Monarch's Small Molecule Tech Enhances SNAP-CAR NK Platform - Stock Titan
Applied Digital Rises 69% in a Month: Buy, Sell or Hold the Stock? - The Globe and Mail
3 Stocks to Buy for a US-China Trade Deal, According to Analysts - The Globe and Mail
(COEP) Technical Pivots with Risk Controls - news.stocktradersdaily.com
When the Price of (COEP) Talks, People Listen - news.stocktradersdaily.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders - Finansavisen
Deal Watch: Lilly Looks To Creyon For Oligonucleotides - insights.citeline.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSESKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Banco - Morningstar
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders - TradingView
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (NasdaqKRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancor - TradingView
Coeptis Therapeutics Announces Reverse Stock Split - GuruFocus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders - Morningstar
Dogecoin (DOGE) Closing To This Number Could Propel It To Another All-Time High - blockzeit.com
Financial Review: Coeptis Therapeutics (NASDAQ:COEP) vs. Immunocore (NASDAQ:IMCR) - Defense World
The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc.COEP - marketscreener.com
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc.COEP - PR Newswire
Here's what to know about the Coeptis-Z-Squared mergerPittsburgh Business Times - The Business Journals
Coeptis Therapeutics Holdings Inc’s Banking’s 100-Day Moving Average at 8.75: Will the Stock Break Through? - investchronicle.com
Biopharma Firm Merges With Z Squared to Form Largest Publicly-Listed Dogecoin Miner - Bitcoin.com News
Coeptis Therapeutics, Z Squared announce merger agreement - MSN
Coeptis Therapeutics, Z Squared enter merger agreement - TipRanks
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss - Benzinga
COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders - Business Wire
Coeptis Therapeutics Subsidiary to Merge With Dogecoin Mining Company - marketscreener.com
Coeptis Therapeutics (COEP) Merges with Z Squared, Shifts to Dig - GuruFocus
Coeptis Therapeutics (COEP) to Merge with Z Squared, Enter Digital Asset Mining | COEP Stock News - GuruFocus
Coeptis Therapeutics and Z Squared to Merge - citybiz
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement - The Manila Times
Coeptis Therapeutics Holdings, Inc. Enters Definitive Merger Agreement with Z Squared Inc. to Pursue Dogecoin Mining Venture - Nasdaq
Massive Crypto Pivot: Biotech Firm Acquires 9,000 Dogecoin Miners in Industry-Shaking Merger - Stock Titan
Bear of the Day: Freshpet (FRPT) - The Globe and Mail
Trend Tracker for (COEP) - news.stocktradersdaily.com
COEPTIS announces strategic tech hub in India By Investing.com - Investing.com Canada
COEPTIS announces strategic tech hub in India - Investing.com India
Coeptis Therapeutics announces establishment of new technology hub in India - TipRanks
COEPTIS, Inc. Announces New Co-Working Technology Hub in India in Partnership with NexGenAI Solutions Group and Ishvara Tech Consulting LLP - Nasdaq
COEPTIS Expands Global AI Footprint: $2.3M New Contracts Plus Advanced Tech Hub Launch in India - Stock Titan
Public market insider buying at VerticalScope Holdings (FORA) - The Globe and Mail
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L - The Globe and Mail
(COEP) On The My Stocks Page - news.stocktradersdaily.com
Coeptis Therapeutics (NASDAQ:COEP) Trading Down 0.8% – What’s Next? - Defense World
Market Analysis: Monday March 31, 2025 - The Globe and Mail
Coeptis Therapeutics Holdings Inc. (COEP) reports earnings - Quartz
Coeptis Therapeutics announces executive departure By Investing.com - Investing.com Canada
Coeptis Therapeutics announces executive departure - Investing.com India
How the (COEP) price action is used to our Advantage - news.stocktradersdaily.com
Coeptis Therapeutics Holdings Inc (COEP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.04%
2.39%
자본화:
|
볼륨(24시간):